157 related articles for article (PubMed ID: 32646936)
1. Rapidly recurring ovarian fibrosarcoma after optimal debulking surgery in a 46-year-old woman.
Winarto H; Hellyanti T; Purbadi S; Sutrisno S
BMJ Case Rep; 2020 Jul; 13(7):. PubMed ID: 32646936
[TBL] [Abstract][Full Text] [Related]
2. Nuclear Atypia Is a Necessary Factor for Diagnosis of Primary Ovarian Fibrosarcoma: A Case Report and Literature Review.
Zhang Z; Yao A; Xin Q; Shi Y; Zhang A
Gynecol Obstet Invest; 2020; 85(5):437-445. PubMed ID: 33011729
[TBL] [Abstract][Full Text] [Related]
3. Ovarian fibrosarcoma with long-term survival: a case report.
Huang YC; Hsu KF; Chou CY; Dai YC; Tzeng CC
Int J Gynecol Cancer; 2001; 11(4):331-3. PubMed ID: 11520377
[TBL] [Abstract][Full Text] [Related]
4. Ovarian dysgerminoma associated with fibrosarcoma: a case report.
Alvarado-Cabrero I; Valencia-Cedillo R; Mohs-Alfaro M; De Anda-González J
Int J Gynecol Pathol; 2011 Sep; 30(5):466-9. PubMed ID: 21804387
[TBL] [Abstract][Full Text] [Related]
5. Primary ovarian fibrosarcoma: a case report and review of the literature.
Ozdemır O; Sarı ME; Sen E; Ilgın BU; Gurescı S; Atalay CR
J Exp Ther Oncol; 2016 Jul; 11(3):225-235. PubMed ID: 28471131
[TBL] [Abstract][Full Text] [Related]
6. [A Case of Recurrent Ovarian Fibrosarcoma Resected by Pancreaticoduodenectomy].
Mizumoto T; Toyama H; Asari S; Goto T; Terai S; Shirakawa S; Nanno Y; Ajiki T; Kido M; Matsumoto T; Tanaka M; Nakamura T; Fukumoto T; Kakeji Y; Ku Y
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2193-2195. PubMed ID: 28133266
[TBL] [Abstract][Full Text] [Related]
7. Ovarian yolk sac tumor associated with major fibrosarcoma component in a 13-year-old girl.
Ali L; Bambach BJ; Kozielski R; Wagner H; Lele S; Mhawech-Fauceglia P
Int J Gynecol Pathol; 2010 May; 29(3):252-5. PubMed ID: 20407325
[TBL] [Abstract][Full Text] [Related]
8. [Primary ovarian fibrosarcoma in a 71-year-old patient].
Tóth F; Csömör S; Zámbó Z
Strahlentherapie; 1971; 141(1):44-6. PubMed ID: 5137504
[No Abstract] [Full Text] [Related]
9. A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome.
Manning-Geist BL; Hicks-Courant K; Gockley AA; Clark RM; Del Carmen MG; Growdon WB; Horowitz NS; Berkowitz RS; Muto MG; Worley MJ
Am J Obstet Gynecol; 2019 Oct; 221(4):326.e1-326.e7. PubMed ID: 31082382
[TBL] [Abstract][Full Text] [Related]
10. Serum HE4 superior to CA125 in predicting poorer surgical outcome of epithelial ovarian cancer.
Shen Y; Li L
Tumour Biol; 2016 Nov; 37(11):14765-14772. PubMed ID: 27629144
[TBL] [Abstract][Full Text] [Related]
11. To compare the optimal cytoreduction rate in advanced epithelial ovarian cancer stage III/IV after 3 versus 6 cycles of neoadjuvant chemotherapy.
Kumari A; Thakur M; Saha SC; Suri V; Prasad GRV; Patel FD; Radhika S
J Obstet Gynaecol; 2021 May; 41(4):616-620. PubMed ID: 32811236
[TBL] [Abstract][Full Text] [Related]
12. A unique fibrous tumor of the ovary: fibrosarcoma or mitotically active cellular fibroma?
Kaku S; Takeshima N; Akiyama F; Furuta R; Hirai Y; Takizawa K
Anticancer Res; 2007; 27(6C):4365-9. PubMed ID: 18214045
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of bowel involvement in optimally cytoreduced advanced ovarian cancer: a retrospective study.
Giorda G; Gadducci A; Lucia E; Sorio R; Bounous VE; Sopracordevole F; Tinelli A; Baldassarre G; Campagnutta E
J Ovarian Res; 2014 Jul; 7():72. PubMed ID: 25328074
[TBL] [Abstract][Full Text] [Related]
14. Ovarian fibrosarcoma: A single-institution experience and a review of the literature.
Sun TT; Cheng NH; Cao DY; Peng P
J Ovarian Res; 2020 Dec; 13(1):142. PubMed ID: 33292402
[TBL] [Abstract][Full Text] [Related]
15. Survival outcomes after delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer.
Yao SE; Tripcony L; Sanday K; Robertson J; Perrin L; Chetty N; Land R; Garrett A; Obermair A; Nascimento M; Tang A; Jagasia N; Singh P; Nicklin J
Int J Gynecol Cancer; 2020 Dec; 30(12):1935-1942. PubMed ID: 33122245
[TBL] [Abstract][Full Text] [Related]
16. Fibrosarcoma: a rare ovarian tumor.
Ducarme G; Wernert R; Fernandez-Valoni A; Voisin-Rigaud C
Eur J Obstet Gynecol Reprod Biol; 2006 Mar; 125(1):141-2. PubMed ID: 16246483
[No Abstract] [Full Text] [Related]
17. Upfront debulking surgery versus interval debulking surgery for advanced tubo-ovarian high-grade serous carcinoma and diffuse peritoneal metastases treated with peritonectomy procedures plus HIPEC.
Biacchi D; Accarpio F; Ansaloni L; Macrì A; Ciardi A; Federici O; Spagnoli A; Cavaliere D; Vaira M; Sapienza P; Sammartino P
J Surg Oncol; 2019 Dec; 120(7):1208-1219. PubMed ID: 31531879
[TBL] [Abstract][Full Text] [Related]
18. Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial.
Shi T; Zhu J; Feng Y; Tu D; Zhang Y; Zhang P; Jia H; Huang X; Cai Y; Yin S; Jiang R; Tian W; Gao W; Liu J; Yang H; Cheng X; Zang R
Lancet Oncol; 2021 Apr; 22(4):439-449. PubMed ID: 33705695
[TBL] [Abstract][Full Text] [Related]
19. Primary debulking surgery of the upper abdomen and the diaphragm, with a plasma device surgery system, for advanced ovarian cancer.
Cordeiro Vidal G; Babin G; Querleu D; Guyon F
Gynecol Oncol; 2017 Jan; 144(1):223-224. PubMed ID: 27836207
[TBL] [Abstract][Full Text] [Related]
20. Patterns of Recurrence and Clinical Outcome of Patients With Stage IIIC to Stage IV Epithelial Ovarian Cancer in Complete Response After Primary Debulking Surgery Plus Chemotherapy or Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery: An Italian Multicenter Retrospective Study.
Gadducci A; Cosio S; Zizioli V; Notaro S; Tana R; Panattoni A; Sartori E
Int J Gynecol Cancer; 2017 Jan; 27(1):28-36. PubMed ID: 27870700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
